Fizazi, A.* , Spinozi, L., Tagliatti, V., De winter, J., Decleves, A.-E., & Colet, J.-M. (13 June 2023). May the post-translational process of succination be involved in cardiac arrhythmia? [Poster presentation]. Mardi des chercheurs, valencienne, France. |
Tagliatti, V., Descamps, C., Lefèvre, M., & Colet, J.-M. (02 June 2023). Predicting Valproate-Induced Liver Injury Using Metabolomic Analysis of Ex Ovo Chick Embryo Allantoic Fluid. Metabolites, 13 (6), 721. doi:10.3390/metabo13060721 Peer reviewed vérifié par ORBi |
Wambreuse, N., Delroisse, J., Tagliatti, V., Eeckhaut, I., Borrello, L., & Caulier, G. (13 December 2022). A multi-omics approach provides a deeper understanding of the immune response of sea cucumber coelomocytes to lipopolysaccharides [Paper presentation]. Fourth Congress of the International Society of Fish and Shellfish immunology, Bodo, Norway. doi:10.1016/j.fsi.2022.10.042 Peer reviewed |
Wambreuse, N., Delroisse, J., Tagliatti, V., Eeckhaut, I., Laura, B., & Caulier, G. (04 October 2022). How de sea cucumbers cope with bacterial infection? Let's bring coelomocytes into the world of omics [Paper presentation]. Sea cucumber aquaculture: new challenges, Concarneau, France. Editorial reviewed |
Wambreuse, N., Delroisse, J., Tagliatti, V., Eeckhaut, I., Laura, B., & Caulier, G. (22 September 2022). The complex immune system of sea cucumbers: a cell story [Paper presentation]. Benelux Congress of Zoology 2022, Courtrai, Belgium. Editorial reviewed |
Denis, J., & Tagliatti, V. (2022). Projet U-Stress : Soirée thématique de l'Institut Santé : Santé et Sport. |
Wambreuse, N., Delroisse, J., Tagliatti, V., Gabriele, S., Deridoux, A., Vanwinge, C., Ormenese, S., Eeckhaut, I., & Caulier, G. (2022). Complex immune system of sea cucumbers - into the secrets of coelomocytes [Paper presentation]. Zoology 2021, Kortrijk, Belgium. Editorial reviewed |
Antoine, M.-H., Husson, C., Yankep, T., Mahria, S., TAGLIATTI, V., Colet, J.-M., & Nortier, J. (2022). Protective Effect of Nebivolol against Oxidative Stress Induced by Aristolochic Acids in Endothelial Cells. Toxins, 14 (2), 132. doi:10.3390/toxins14020132 Peer reviewed vérifié par ORBi |
Soumoy, L., Krayem, M., Tagliatti, V., Ghanem, G., Saussez, S., & Journe, F. (07 December 2021). Bufalin to fight persister cells and breakdown resistance to targeted therapies in metastatic melanoma [Poster presentation]. EACR-AstraZeneca Virtual Conference 'Drug Tolerant Persister Cells', . |
Soumoy, L., Krayem, M., Tagliatti, V., Ghanem, G., Saussez, S., & Journe, F. (03 December 2021). Targeting tumor cell metabolic plasticity to breakdown resistance to targeted therapies in metastatic melanoma [Paper presentation]. ESPCR-2021, Virtual, Unknown/unspecified. |
Draguet, A., Tagliatti, V., Colet, J.-M., & Gillet, J.-P. (25 November 2021). ABCB5 et les résistances des mélanomes aux médicaments - Evaluation métabonomique in vivo par 1H-RMN [Poster presentation]. Networking EpiCURA-UMONS, Baudour, Belgium. |
Tagliatti, V., Colet, J.-M., Decleves, A.-E., & Debelle, F. (25 November 2021). Etude longitudinale de la transition de la souffrance rénale aiguë vers la maladie rénale chronique chez les patients COVID-19 (Metabo-Cov AKI-to-CKD) [Paper presentation]. Networking EpiCURA-UMONS, Baudour, Belgium. |
Decarnoncle, M., Decroo, C., Coppée, F., Tassin, A., Tagliatti, V., Villers, A., Colet, J.-M., Nonclercq, D., Legrand, A., Ris, L., Wattiez, R., & Decleves, A.-E. (25 November 2021). Développement d'une trousse de dosage d'organokines par spectrométrie de masse [Poster presentation]. Networking EpiCURA-UMONS, Baudour, Belgium. |
Draguet, A., Tagliatti, V., & Colet, J.-M. (25 November 2021). Cibler la reprogrammation métabolique pour améliorer le cancer du sein : évaluation d'inhibiteurs métaboliques par approche métabonomique [Paper presentation]. Networking EpiCURA-UMONS, Baudour, Belgium. |
Colet, J.-M., & Tagliatti, V. (2021). Approche métabolomique in vitro du stress oxydatif induit par les acides aristolochiques sur la cellule endothéliale [Paper presentation]. Congrès de Société Francophone de Néphrologie Dialyse et Transplantation, Toulouse, France. |
Tagliatti, V. (2021). Initiation certificative aux modèles et méthodes en sciences biomédicales. |
Nortier, J., Antoine, M. H., Husson, C., Tagliatti, V., & Colet, J.-M. (September 2021). Approche métabolomique in vitro du stress oxydatif induit par les acides aristolochiques sur la cellule endothéliale. Néphrologie & Thérapeutique, 17 (5), 303. doi:10.1016/j.nephro.2021.07.149 Peer reviewed |
Draguet, A., Tagliatti, V., & Colet, J.-M. (2021). Targeting Metabolic Reprogramming to Improve Breast Cancer Treatment: An In Vitro Evaluation of Selected Metabolic Inhibitors Using a Metabolomic Approach. Metabolites. Peer reviewed vérifié par ORBi |
Tagliatti, V., & Labiau, L. (2021). Carnet de suivi 2. |
Fourez, S., Tagliatti, V., & Colet, J.-M. (2021). Cardiotoxicité induite par la Doxorubicine Etude in vitro de l'implication du nicotinamide riboside (NR) dans la toxicité [Master’s dissertation, Université de Mons]. ORBi UMONS-University of Mons. https://orbi.umons.ac.be/handle/20.500.12907/30109 |
Draguet, A., Tagliatti, V., Schepkens, C., & Colet, J.-M. (17 June 2021). An in vitro metabonomic approach to evaluate metabolic inhibitors either in monotherapy or coupled with Doxorubicin [Poster presentation]. Metabolomics 2021, . |
Soumoy, L., Krayem, M., Tagliatti, V., Ghanem, G., Saussez, S., & Journe, F. (10 June 2021). Evaluating metabolic reprogramming in metastatic melanoma with resistance to targeted therapies to assess new targets for treatment [Poster presentation]. EACR-2022, Virtual, Unknown/unspecified. |
Delcourt, M., Delsinne, V., Colet, J.-M., Decleves, A.-E., & Tagliatti, V. (29 April 2021). Investigation of Mitochondrial Adaptations to Modulation of Carbohydrate Supply during Adipogenesis of 3T3-L1 Cells by Targeted H-NMR Spectroscopy. Biomolecules, 11 (5). Peer reviewed |
Draguet, A., Tagliatti, V., & Colet, J.-M. (26 April 2021). La métabonomique par résonance magnétique nucléaire du proton (1H-RMN) : deux applications dans notre laboratoire [Poster presentation]. Evènement de maillage UMHAP, Mons, Belgium. |
Chaumont, M., Communi, D., Tagliatti, V., Colet, J.-M., & van de Borne, P. (15 April 2021). SERUM PROTEOME AND HIGH WATTAGE E-CIGARETTE VAPING: A RANDOMIZED CROSSOVER STUDY. Journal of Hypertension, 39 (pe 167), 167. Peer reviewed vérifié par ORBi |
Chaumont, M., Communi, D., Tagliatti, V., Colet, J.-M., & van de Borne, P. (2021). HIGH WATTAGE VAPING SHIFTS URINE METABOLOME TOWARD A HEALTHIER PROFILE: A RANDOMIZED CROSSOVER STUDY. Journal of Hypertension, (pi), 167-168. Peer reviewed vérifié par ORBi |
Leclercq, S., Tagliatti, V., Colet, J.-M., & (en collaboration avec 10 personnes. (13 October 2020). Gut Microbiota-Induced Changes in β-Hydroxybutyrate Metabolism Are Linked to Altered Sociability and Depression in Alcohol Use Disorder. Cell Reports, 33 (108238), 1-24. doi:10.1016/j.celrep.2020.108238 Peer reviewed |
Delcourt, M., Tagliatti, V., Delsinne, V., Colet, J.-M., & Decleves, A.-E. (29 September 2020). Influence of Nutritional Intake of Carbohydrates on Mitochondrial Structure, Dynamics, and Functions during Adipogenesis. Nutrients, 12. doi:10.3390/nu12102984 Peer reviewed vérifié par ORBi |
Dallons, M., Alpan, E., Schepkens, C., Tagliatti, V., & Colet, J.-M. (2020). GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells. Cells. Peer reviewed |
Soumoy, L., Schepkens, C., Krayem, M., Ahmad, N., Tagliatti, V., Ghanem, E. G., Saussez, S., Colet, J.-M., & Journe, F. (22 May 2020). Metabolic Reprogramming in Metastatic Melanoma with Acquired Resistance to Targeted Therapies: Integrative Metabolomic and Proteomic Analysis. Cancers, 12 (5), 12-23. doi:10.3390/cancers12051323 Peer reviewed |
Dallons, M., Schepkens, C., Dupuis, A., Tagliatti, V., & Colet, J.-M. (2020). New Insights About Doxorubicin-Induced Toxicity to Cardiomyoblast-Derived H9C2 Cells and Dexrazoxane Cytoprotective Effect: Contribution of In Vitro1H-NMR Metabonomics. Frontiers in Pharmacology. Peer reviewed vérifié par ORBi |
Soumoy, L., Trelcat, A., Schepkens, C., Tagliatti, V., Ghanem, G., Saussez, S., & Journe, F. (31 January 2020). Metabolic switch in melanoma cells with acquired resistance to targeted therapies [Poster presentation]. BACR Annual meeting, Jette, Belgium. |
Soumoy, L., Trelcat, A., Schepkens, C., Tagliatti, V., Ghanem, G., Saussez, S., & Journe, F. (31 January 2020). Metabolic switch in melanoma cells with acquired resistance to targeted therapies [Poster presentation]. 14th meeting of the FRS-FNRS Contact group on Oxidative Proceses and Antioxidants, UMONS, Belgium. |
Dallons, M., & Tagliatti, V. (31 January 2020). Development and validation of an in vitro fluorimetric quantification method of ROS generation using the DCFH-DA probe to detect quickly the presence of a drug-induced oxidative stress [Poster presentation]. 14th meeting of the FRS-FNRS Contact group on oxidative stress and antioxidants, Mons, Belgium. |
Dallons, M., & Tagliatti, V. (31 January 2020). Development and validation of an in vitro fluorimetric quantification method of ROS generation using the DCFH-DA probe to detect quickly the presence of a drug-induced oxidative stress [Paper presentation]. 14th meeting of the FRS-FNRS Contact group on oxidative stress and antioxidants, Mons, Belgium. |
Dallons, M., & Tagliatti, V. (21 November 2019). Contribution of in vitro 1H-NMR metabonomics for studying doxorubicin-induced cardiotoxicity and protective effects of dexrazoxane [Paper presentation]. EMBO-EMBL Symposium - Metabolism Meets Epigenetics 2019, Heidelberg, Germany. |
Dallons, M., & Tagliatti, V. (21 November 2019). Contribution of in vitro 1H-NMR metabonomics for studying doxorubicin-induced cardiotoxicity and protective effects of dexrazoxane [Poster presentation]. EMBO-EMBL Symposium - Metabolism Meets Epigenetics 2019, Heidelberg, Germany. |
Chaumont, M., Tagliatti, V., & Colet, J.-M. (2019). Short halt in vaping modifies cardio-respiratory parameters and urine metabolome: a randomized trial. American Journal of Physiology - Lung Cellular and Molecular Physiology. Peer reviewed vérifié par ORBi |
Soumoy, L., Krayem, M., Tagliatti, V., Ghanem, G., Saussez, S., & Journe, F. (25 October 2019). Mechanisms of resistance in melanoma cells and the role of Mnk proteins in these processes [Poster presentation]. 4th symposium of the ULB-cancer research center, Brussels , Belgium. |
Colet, J.-M., Pamart, L., Tagliatti, V., Delsinne, V., & Kahvecioglu, Z. C. (2019). Biologie Générale Humaine : Travaux pratiques. |
Furgiuele, S., Descamps, G., Tafforeau, L., Tagliatti, V., Journe, F., & Saussez, S. (06 September 2019). Development and application of the CRISPR-Cas9 technique in human cell lines of head and neck cancers infected with human papillomavirus [Poster presentation]. Ecole Doctorale en Cancérologie, UCL, Belgium. Peer reviewed |
Soumoy, L., Najem, A., Krayem, M., Tagliatti, V., Ghanem, G., Saussez, S., & Journe, F. (06 September 2019). Mechanisms of resistance in melanoma cells and the role of Mnk proteins in these processes [Paper presentation]. EDT-Cancerology Annual Meeting 2019, UCLouvain, Belgium. |
Colet, J.-M., Tagliatti, V., & Auquier, G. (2019). Etude in vitro de l'influence de la sarcosine sur la division, la migration et la reprogrammation métabolique de cellules cancéreuses prostatiques et mammaires [Master’s dissertation, Université de Mons]. ORBi UMONS-University of Mons. https://orbi.umons.ac.be/handle/20.500.12907/30096 |
Soumoy, L., Krayem, M., Tagliatti, V., Ghanem, G., Saussez, S., & Journe, F. (05 March 2019). New combinations of targeted therapies in melanoma [Poster presentation]. Mardi des Chercheurs, Mons, Belgium. |
Valentini, X., Rugira Uwamahoro, P., Frau, A., Tagliatti, V., Conotte, R., Laurent, S., Colet, J.-M., & Nonclercq, D. (03 March 2019). Hepatic and renal toxicity induced by TiO2 nanoparticles in rats : a morphological and metabonomic study. Journal of Toxicology, 2019. Peer reviewed vérifié par ORBi |
Soumoy, L., Krayem, M., Tagliatti, V., Ghanem, G., Saussez, S., & Journe, F. (01 February 2019). New combinations of targeted therapies in melanoma [Poster presentation]. BACR Annual meeting, Antwerpen, Belgium. |
Romoaldo, G., Hambye, S., Tagliatti, V., Colet, J.-M., & Blankert, B. (12 September 2018). Assessing emotional states.: Metabonomic profiling and quantification of a salivary biomarker [Paper presentation]. DA-PBA 2018 : 11th International symposium on Drug Analysis - 29th International Symposium on Pharmaceutical and Biomedical Analysis, Leuven, Belgium. Peer reviewed |
Romoaldo, G., Hambye, S., Tagliatti, V., Blankert, B., & Colet, J.-M. (23 July 2018). Influence of psychosocial stress on salivary metabonomic profile [Paper presentation]. 11e journées scientifiques du Réseau Francophone de Métabonomique et fluxomique, Liège, Belgium. |
Romoaldo, G., Hambye, S., Tagliatti, V., Colet, J.-M., & Blankert, B. (12 July 2018). STRESS AND SALIVA: BIOMARKER QUANTIFICATION AND METABONOMIC PROFILING [Poster presentation]. 2nd International Symposium on Advances in Pharmaceutical Analysis, Lille, France. |
Romoaldo, G., Hambye, S., Tagliatti, V., Blankert, B., & Colet, J.-M. (23 May 2018). Influence of psychosocial stress on salivary metabonomic profile [Poster presentation]. 11e journées scientifiques du Réseau Francophone de Métabonomique et fluxomique, Liège, Belgium. |
Dallons, M., & Tagliatti, V. (23 May 2018). Doxorubicin-induced metabolic alterations in H9C2 cells and effects of preincubation with dexrazoxane, a cardioprotective agent [Paper presentation]. 11èmes journées scientifiques du RFMF, Liège, Belgium. |
Dallons, M., & Tagliatti, V. (23 May 2018). Doxorubicin-induced metabolic alterations in H9C2 cells and effects of preincubation with dexrazoxane, a cardioprotective agent [Poster presentation]. 11èmes journées scientifiques du RFMF, Liège, Belgium. |
Dallons, M., & Tagliatti, V. (01 April 2018). Study of the metabolic doxorubicine-induced alterations in H9C2 cells and the effect of preincubation with dexrazoxane, a cardioprotective agent [Paper presentation]. 15 International Youth School-Conference 'Magnetic resonance and its applications - Spinus-2018, Saint-Pétersbourg, Russia. |
Furgiuele, S., Tagliatti, V., & Colet, J.-M. (2018). Recherche de biomarqueurs d'efficacité en immunothérapie par approche métabonomique expérimentale et clinique [Master’s dissertation, Université de Mons]. ORBi UMONS-University of Mons. https://orbi.umons.ac.be/handle/20.500.12907/16144 |
Maroil, D., Delsinne, V., & Tagliatti, V. (2018). Metabonomic study of the hypothyroidism effect of sunitinib, a multiple inhibitor of tyrosine kinase receptors, by metabonomic approach in the rat [Poster presentation]. 15 International Youth School-Conference 'Magnetic resonance and its applications - Spinus-2018, Saint-Pétersbourg, Russia. |
Romoaldo, G., Hambye, S., Tagliatti, V., Colet, J.-M., & Blankert, B. (14 September 2017). Emotions and saliva: Metabonomic profiling and quantification of salivary biomarkers [Paper presentation]. EDT Scieces pharmaceutiques : PHD Day, Spa, Unknown/unspecified. |
Romoaldo, G., Blidar, A., Hambye, S., Tagliatti, V., Colet, J.-M., & Blankert, B. (15 June 2017). Assessing emotional states: Metabonomic profiling and quantification of a salivary biomarker [Poster presentation]. 45th international symposium on high performance liquid separations and related techniquestechniques, Prague, Czechia. |
Romoaldo, G., Hambye, S., Tagliatti, V., Colet, J.-M., & Blankert, B. (2017). Un voyage émotionnel à travers la salive. |
Romoaldo, G., Hambye, S., Tagliatti, V., Colet, J.-M., & Blankert, B. (30 March 2017). Évaluer les états émotionnels : profilage métabonomique et quantification d'un biomarqueur salivaire [Poster presentation]. 12ème Congrès de l'Association Francophone des Sciences Séparatives, Paris, France. |
Romoaldo, G., Hambye, S., Tagliatti, V., Colet, J.-M., & Blankert, B. (2017). Un voyage émotionnel à travers la salive. |
Romoaldo, G., Hambye, S., Tagliatti, V., Colet, J.-M., & Blankert, B. (07 March 2017). Stress and saliva : physiological impact of psychosocial stress [Poster presentation]. Huitième édition montoise du MdC : le Mardi des Chercheurs 2017, UMons, Belgium. |
Tagliatti, V., & Colet, J.-M. (24 November 2016). Drug-Induced Impairment of Mitochondrial Fatty Acid Be- ta-Oxidation: A Metabonomic Evaluation in Rats. HSOA Journal of Medical Genomics and Biomarkers, 3 (005). Peer reviewed |
Romoaldo, G., Hambye, S., Tagliatti, V., Colet, J.-M., & Blankert, B. (17 October 2016). Assessing emotional states : metabonomic profiling and quantification of a salivary biomarker [Paper presentation]. 19th Forum of Pharmaceutical Sciences, Bruxelles, Belgium. |
Delcourt, M., Tagliatti, V., Conotte, R., & Colet, J.-M. (21 September 2016). Metabonomics as an indicative tool to understand metabolic disruption linked to diet, diseases & drugs [Poster presentation]. Workshop NutriOx 2016, Kaiserslautern, Unknown/unspecified. |
Tagliatti, V., Conotte, R., De Luca, D., Podrecca, M., & Colet, J.-M. (21 September 2016). Metabonomics applied to toxicology and clinical studies [Poster presentation]. Workshop NutriOx 2016, Kaiserslautern, Unknown/unspecified. |
Romoaldo, G., Hambye, S., Tagliatti, V., Colet, J.-M., & Blankert, B. (18 May 2016). Objectiver les états émotionnels : approche métabonomique et quantification d'un biomarqueur salivaire [Poster presentation]. 9ème édition de la Matinée des Chercheurs 2016 (MdC2016), Valenciennes, France. |
Tagliatti, V., & Colet, J.-M. (10 May 2015). Evaluation des atteintes des voies biochimiques mitochondriales par approche métabonomique [Poster presentation]. Congrès Meetochondrie, Guidel-Plages, France. |
Vanderkam, L., Tagliatti, V., & Colet, J.-M. (10 May 2015). Etude par approche métabonomique de l'altération des voies biochimiques mitochondriales dans la maladie d'Alzheimer [Poster presentation]. Congrès Meetochondrie, Guidel-Plages, France. |
Tagliatti, V. (2014). Évaluation des perturbations des voies biochimiques mitochondriales par approche métabonomique. : Une étude séquentielle de l'organite à l'organisme [Doctoral thesis, Université de Mons]. ORBi UMONS-University of Mons. https://orbi.umons.ac.be/handle/20.500.12907/21095 |
Tagliatti, V. (16 May 2013). From subcellular to whole organism exploration of drugs adverse effects by metabonomics [Paper presentation]. 1st Belgian-Netherlands joint symposium on metabolomics : Translational approaches in Metabolomics, Spa, Belgium. |
De Luca, D., & Tagliatti, V. (2013). From subcellular to whole organism exploration of drug adverse effects by metabonomics [Paper presentation]. First Belgian-Netherlands Joint symposium on Metabolomics, Spa, Belgium. Editorial reviewed |
Tagliatti, V. (12 May 2012). Metabonomics applied to Toxicology and Clinical Studies [Poster presentation]. 10° Réunion du groupe de contact FNRS, Mons, Belgium. |
Podrecca, M., Conotte, R., De Luca, D., Tagliatti, V., & Colet, J.-M. (2012). Metabonomics Applied to Toxicology and Clinical Studies [Poster presentation]. 10th 'Oxidative stress and genotoxic response' meeting, Mons, Belgium. |
Tagliatti, V. (22 November 2011). Valproate-induced liver mitochondrial dysfunction in rats : a Metabonomic approach [Paper presentation]. 10th symposium Young Belgian Magnetic Resonance Scientists; FNRS, Blankenberge, Belgium. |
Tagliatti, V., Conotte, R., De Luca, D., & Colet, J.-M. (28 August 2011). Valproate-induced Liver Mitochondrial Dysfunction in Rats : a Metabonomic Approach. Toxicology Letters, 205, 277. Peer reviewed vérifié par ORBi |
Conotte, R., Tagliatti, V., De Luca, D., & Colet, J.-M. (28 August 2011). Metabonomic Evaluation of Oxaliplatin Hepatotoxicity by Comparison with a Sinusoidal Obstruction Syndrome (SOS) Model [Poster presentation]. 47th Congress of the European Societies of Toxicology, Paris, France. |
Tagliatti, V., Conotte, R., De Luca, D., & Colet, J.-M. (28 August 2011). Valproate-induced Liver Mitochondrial Dysfunction in Rats : a Metabonomic Approach [Poster presentation]. 47th Congress of the European Societies of Toxicology, Paris, France. |
Tagliatti, V., Conotte, R., & Colet, J.-M. (2011). An isolated and perfused organ approach to validate biomarkers of toxicity identified in metabonomics studies [Paper presentation]. 47th Congress of the European Societies of Toxicology, Paris, France. doi:10.1016/j.toxlet.2010.03.503 |
De Luca, D., Tagliatti, V., Conotte, R., & Colet, J.-M. (28 August 2011). Chlordecone Potentiation of Carbon Tetrachloride Toxicity : a Metabonomic-based Mechanistic Study [Poster presentation]. 47th Congress of the European Societies of Toxicology, Paris, France. |
Conotte, R., De Luca, D., Tagliatti, V., & Colet, J.-M. (28 August 2011). Metabonomic Evaluation of Oxaliplatin Hepatotoxicity by Comparison with a Sinusoidal Obstruction Syndrome (SOS) Model. Toxicology Letters, 205, 181. Peer reviewed vérifié par ORBi |
De Luca, D., Tagliatti, V., Conotte, R., & Colet, J.-M. (28 August 2011). Chlordecone Potentiation of Carbon Tetrachloride Toxicity : a Metabonomic-based Mechanistic Study. Toxicology Letters, 205, 181-S182. Peer reviewed vérifié par ORBi |
Tagliatti, V. (18 May 2011). Une Approche Métabonomique de la Toxicité Mitochondriale [Poster presentation]. Second Belgian Symposium in Metabolomics and Metabonomics, Liège, Belgium. |
Tagliatti, V. (02 May 2011). Une Approche Métabonomique de la Toxicité Mitochondriale [Poster presentation]. 5ème Colloque MeetOchondrie, Colle-sur-Loup, France. |
Podrecca, M., Conotte, R., Tagliatti, V., De Luca, D., & Colet, J.-M. (22 March 2011). Application de la Métabonomique en Toxicologie [Poster presentation]. Matinée des chercheurs, UMONS, Belgium. |
Tagliatti, V., Conotte, R., & Colet, J.-M. (01 July 2010). Metabonomics fingerprint of the isolated and perfused liver [Poster presentation]. XII international congress of toxicology - IUTOX 2010, Barcelone, Spain. |
Tagliatti, V., Conotte, R., & Colet, J.-M. (01 June 2010). Metabonomics fingerprint of the isolated and perfused liver [Poster presentation]. Metabolomics conference 2010, Amsterdam, Netherlands. |